We are proud to announce that Enza Biotech is now part of Croda International Plc., a perfect partnership for bringing our sustainable and innovative surfactant platform to market. Croda’s technical and formulation expertise, global operational footprint and sales force paired with their track record of bringing new technologies to market make them a perfect home for Enza’s OLMAG® technology. We are looking forward to working with the Croda team to create new opportunities together.
Enza Biotech was granted 300.000 SEK from Vinnova for developing their OLMAG® surfactant platform.
Stefan Ulvenlund presented Enza’s oligomeric alkyl glycoside technology at the Formula VIII conference (July 4-7 2016) in Barcelona in a talk with the title “Oligomeric Alkylglycoside Surfactants: New power-tools in the formulation toolbox”
On June 8 OLMAG® was approved and registered as trademark in the European Union.
Enza Biotech shared a booth with three other innovative Lund-based companies: CR Competence, Senzagen and Speximo and met with many companies who expressed an interest for Enza’s oligomeric alkylglycoside technology. 
Produced by Avyno
Copyright © Enza Biotech
